elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34134828-7CDF96B7-3D9C-4EA6-9BDE-C63166C3743E
Q34134828-7CDF96B7-3D9C-4EA6-9BDE-C63166C3743E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34134828-7CDF96B7-3D9C-4EA6-9BDE-C63166C3743E
Selective estrogen receptor modulators: tissue specificity and clinical utility.
P2860
Q34134828-7CDF96B7-3D9C-4EA6-9BDE-C63166C3743E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34134828-7CDF96B7-3D9C-4EA6-9BDE-C63166C3743E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
55f577a2a820bdb250ecdd6d70fb193a5d4e45e7
P2860
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients.